PDS Biotechnology
PDSB
PDSB
78 hedge funds and large institutions have $39.7M invested in PDS Biotechnology in 2023 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 24 increasing their positions, 25 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
78
Holders Change
-2
Holders Change %
-2.5%
% of All Funds
1.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
24
Reduced
25
Closed
12
Calls
$1.62M
Puts
$1.58M
Net Calls
+$43K
Net Calls Change
-$69K
Top Buyers
| 1 |
TCM
1
Tang Capital Management
San Diego,
California
|
$2.02M |
| 2 |
2
BlackRock
New York
|
$9.11M |
| 3 |
3
State Street
Boston,
Massachusetts
|
$2.55M |
| 4 |
4
Citadel Advisors
Miami,
Florida
|
$485K |
| 5 |
TI
5
Trexquant Investment
Stamford,
Connecticut
|
$131K |
Top Sellers
| 1 |
1
Two Sigma Advisers
New York
|
$1.27M |
| 2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$7.61M |
| 3 |
3
Two Sigma Investments
New York
|
$644K |
| 4 |
JF
4
Jump Financial
Chicago,
Illinois
|
$86.4K |
| 5 |
5
LPL Financial
San Diego,
California
|
$1.19M |
